503 related articles for article (PubMed ID: 24607230)
21. Effect of ifenprodil on GluN1/GluN2B N-methyl-D-aspartate receptor gating.
Bhatt JM; Prakash A; Suryavanshi PS; Dravid SM
Mol Pharmacol; 2013 Jan; 83(1):9-21. PubMed ID: 23007555
[TBL] [Abstract][Full Text] [Related]
22. Mg2+ block properties of triheteromeric GluN1-GluN2B-GluN2D NMDA receptors on neonatal rat substantia nigra pars compacta dopaminergic neurones.
Huang Z; Gibb AJ
J Physiol; 2014 May; 592(10):2059-78. PubMed ID: 24614743
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of N-methyl-D-aspartate receptor-mediated excitatory postsynaptic potentials and synaptic plasticity to TCN 201 and TCN 213 in rat hippocampal slices.
Izumi Y; Zorumski CF
J Pharmacol Exp Ther; 2015 Feb; 352(2):267-73. PubMed ID: 25413830
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of rat recombinant GluN1/GluN2A and GluN1/GluN2B NMDA receptors by ethanol at concentrations based on the US/UK drink-drive limit.
Otton HJ; Janssen A; O'Leary T; Chen PE; Wyllie DJ
Eur J Pharmacol; 2009 Jul; 614(1-3):14-21. PubMed ID: 19394328
[TBL] [Abstract][Full Text] [Related]
25. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
26. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
[TBL] [Abstract][Full Text] [Related]
27. A conserved structural mechanism of NMDA receptor inhibition: A comparison of ifenprodil and zinc.
Sirrieh RE; MacLean DM; Jayaraman V
J Gen Physiol; 2015 Aug; 146(2):173-81. PubMed ID: 26170175
[TBL] [Abstract][Full Text] [Related]
28. Deletion of the N-terminal domain alters the ethanol inhibition of N-methyl-D-aspartate receptors in a subunit-dependent manner.
Smothers CT; Jin C; Woodward JJ
Alcohol Clin Exp Res; 2013 Nov; 37(11):1882-90. PubMed ID: 23905549
[TBL] [Abstract][Full Text] [Related]
29. Stationary gating of GluN1/GluN2B receptors in intact membrane patches.
Amico-Ruvio SA; Popescu GK
Biophys J; 2010 Apr; 98(7):1160-9. PubMed ID: 20371315
[TBL] [Abstract][Full Text] [Related]
30. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
[TBL] [Abstract][Full Text] [Related]
31. Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo.
Gray JA; Shi Y; Usui H; During MJ; Sakimura K; Nicoll RA
Neuron; 2011 Sep; 71(6):1085-101. PubMed ID: 21943605
[TBL] [Abstract][Full Text] [Related]
32. Triheteromeric GluN1/GluN2A/GluN2C NMDARs with Unique Single-Channel Properties Are the Dominant Receptor Population in Cerebellar Granule Cells.
Bhattacharya S; Khatri A; Swanger SA; DiRaddo JO; Yi F; Hansen KB; Yuan H; Traynelis SF
Neuron; 2018 Jul; 99(2):315-328.e5. PubMed ID: 30056832
[TBL] [Abstract][Full Text] [Related]
33. Novel Mode of Antagonist Binding in NMDA Receptors Revealed by the Crystal Structure of the GluN1-GluN2A Ligand-Binding Domain Complexed to NVP-AAM077.
Romero-Hernandez A; Furukawa H
Mol Pharmacol; 2017 Jul; 92(1):22-29. PubMed ID: 28468946
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site.
Kvist T; Steffensen TB; Greenwood JR; Mehrzad Tabrizi F; Hansen KB; Gajhede M; Pickering DS; Traynelis SF; Kastrup JS; Bräuner-Osborne H
J Biol Chem; 2013 Nov; 288(46):33124-35. PubMed ID: 24072709
[TBL] [Abstract][Full Text] [Related]
35. NMDA Receptor GluN2 Subtypes Control Epileptiform Events in the Hippocampus.
Punnakkal P; Dominic D
Neuromolecular Med; 2018 Mar; 20(1):90-96. PubMed ID: 29335819
[TBL] [Abstract][Full Text] [Related]
36. Cryo-EM structures of the triheteromeric NMDA receptor and its allosteric modulation.
Lü W; Du J; Goehring A; Gouaux E
Science; 2017 Mar; 355(6331):. PubMed ID: 28232581
[No Abstract] [Full Text] [Related]
37. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
38. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
[TBL] [Abstract][Full Text] [Related]
39. Ethanol inhibition of constitutively open N-methyl-D-aspartate receptors.
Xu M; Smothers CT; Trudell J; Woodward JJ
J Pharmacol Exp Ther; 2012 Jan; 340(1):218-26. PubMed ID: 22005043
[TBL] [Abstract][Full Text] [Related]
40. A novel family of negative and positive allosteric modulators of NMDA receptors.
Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
